More highlights from AAP San Diego!

Article

The first 3 days of the American Academy of Pediatrics (AAP) 2014 National Conference and Exhibition in San Diego have featured stimulating and thought-provoking plenary and educational sessions as well as forums, focus groups, and industry- and foundation-sponsored symposia.

The first 3 days of the American Academy of Pediatrics (AAP) 2014 National Conference and Exhibition in San Diego have featured stimulating and thought-provoking plenary and educational sessions as well as forums, focus groups, and industry- and foundation-sponsored symposia. Attendees have explored the exhibit hall, networked with colleagues, and heard the experts disclose the latest advances and best practices in pediatric care. Contemporary Pediatrics presents just a few examples of the best-in-class programs from the conference schedule.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Related Content
Can you diagnose this 11-year-old with a petechial rash? | Image credit: Author provided

Can you diagnose this 11-year-old with a petechial rash?

Drashti Patel, BS, BA;Jyoti Budania, MD
July 8th 2025
Article

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency | © Contemporary Pediatrics

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

Morgan Ebert, Managing Editor
July 8th 2025
Article

The FDA accepted Eton Pharmaceuticals' NDA for ET-600 for pediatric arginine vasopressin deficiency, with a target action date in February of 2026.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
AAP, other medical societies sue HHS, Robert F. Kennedy Jr. over vaccine advices | Image Credit: © Rafael Henrique - © Rafael Henrique - stock.adobe.com.

AAP, other medical societies sue HHS, Robert F. Kennedy Jr. over vaccine practices

Joshua Fitch, Senior Editor
July 7th 2025
Article

Six medical societies, including the American Academy of Pediatrics, are suing the HHS and its Secretary to "defend vaccine policy."

FDA approves sebetralstat as first and only on-demand treatment for HAE | Image Credit: Contemporary Pediatrics

FDA approves sebetralstat as first and only on-demand treatment for HAE

Joshua Fitch, Senior Editor
July 7th 2025
Article

Though the original target action date was not met by the FDA, KalVista's sebetralstat is now approved to treat HAE in patients 12 years and older.

© 2025 MJH Life Sciences

All rights reserved.